Article Information
History
- April 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Björn Corleis#,1,
- Donata Hoffmann#,2,
- Susanne Rauch3,
- Charlie Fricke1,
- Nicole Roth3,
- Janina Gergen3,
- Kristina Kovacikova3,
- Kore Schlottau2,
- Nico Joel Halwe2,
- Lorenz Ulrich2,
- Jacob Schön2,
- Kerstin Wernike2,
- Marek Widera4,
- Sandra Ciesek4,5,6,
- Stefan O. Mueller3,
- Thomas C. Mettenleiter7,
- Benjamin Petsch3,
- Martin Beer*,#,2 and
- Anca Dorhoi*,#,1
- 1Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
- 2Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
- 3CureVac AG, Tübingen, Germany
- 4Institute for Med. Virology, University Hospital Frankfurt, Goethe University Frankfurt, Paul-Ehrlich-Str.40, 60596 Frankfurt am Main
- 5German Center for Infection Research (DZIF), 38124 Braunschweig, Germany
- 6Branch Translational Medicine and Pharmacology, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), 60596 Frankfurt am Main, Germany
- 7Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
- ↵*Corresponding author. email: anca.dorhoi{at}fli.de
↵# Contributor Information: Contributed equally.